Exhaled nitric oxide and bronchial hyperresponsiveness in patients with a) mild asthma and b) seasonal allergic rhinitis. Relationship to symptoms Source: Eur Respir J 2001; 18: Suppl. 33, 165s Year: 2001
Exhaled NO in upper and lower airways in patients with allergic rhinitis and asthma Source: Eur Respir J 2003; 22: Suppl. 45, 110s Year: 2003
Exhaled NO is independently related to the degree of allergic sensitisation and bronchial resposiveness in atopic subjects Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control Year: 2010
Exhaled NO in relation to atopy and rhinitis symptoms Source: Eur Respir J 2001; 18: Suppl. 33, 269s Year: 2001
Predicting exacerbations: asthma, allergy and exhaled NO Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009
Local cytokine profile specifics among patients with BA phenotype, associated to allergic rhinitis: allergic rhinitis and bronchial asthma. Source: International Congress 2018 – Physiological and biological insights in asthma Year: 2018
Small airways dysfunction: the link between allergic rhinitis and allergic asthma Source: Eur Respir J, 51 (2) 1701749; 10.1183/13993003.01749-2017 Year: 2018
Comparison of nasal steroids, antileukotrienes and combination therapy in seasonal allergic rhinitis: effect on exhaled breath markers Source: Eur Respir J 2003; 22: Suppl. 45, 109s Year: 2003
Atopy but no bronchial hyperresponsiveness (BHR) is related to level of exhaled nitric oxide (FeNO) in children with allergic rhinitis Source: Annual Congress 2008 - Exercise-induced asthma, acute severe asthma and allergic rhinitis in children Year: 2008
Control of allergic rhinitis and asthma test, asthma control test and FeNO in asthma Source: Annual Congress 2012 - Aspects of clinical asthma Year: 2012
To assess the effects of combined nasal and inhaled corticosteroid in patients with asthma and persistent allergic rhinitis Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009
Effect of adding montelukast on asthma and rhinitis in asthma patients with concomitant allergic rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 121s Year: 2006
Exhaled nitric oxide and lower airway involvement in persistent rhinitis Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006
Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009
Bronchial hyperresponsiveness (BHR) in children with allergic rhinitis (AR) and its relationship to exhaled nitric oxide (FeNO) Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009
Bronchial challenge test and related factors in the presence of bronchial asthma and/or allergic rhinitis symptoms Source: Eur Respir J 2005; 26: Suppl. 49, 130s Year: 2005
Evaluation of asthma patients using the control of allergic rhinitis and asthma test (CARAT) Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012
Exhaled breath profiling by electronic nose enabled discrimination of allergic rhinitis and extrinsic asthma. Source: International Congress 2018 – Clinical and functional monitoring in airway disease Year: 2018
Changes in lung functions and inflammatory markers in induced sputum of patients with bronchial asthma and allergic rhinitis in relation to exposure to pollen allergens Source: Eur Respir J 2005; 26: Suppl. 49, 734s Year: 2005
Sputum eosinophilia vs exhaled NO as markers of airways inflammation in asthma: relationship with asthma control Source: Eur Respir J 2005; 26: Suppl. 49, 736s Year: 2005